v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 28, 2025
Dec. 29, 2024
Current assets:    
Cash and cash equivalents $ 19,709 $ 24,105
Marketable securities 393 417
Accounts receivable trade, less allowances $183 (2024, $167) 17,178 14,842
Inventories 14,191 12,444
Prepaid expenses and other receivables 4,153 4,085
Total current assets 55,624 55,893
Property, plant and equipment, net 23,169 20,518
Intangible assets, net 50,403 37,618
Goodwill 48,772 44,200
Deferred taxes on income 6,874 10,461
Other assets 14,368 11,414
Total assets 199,210 180,104
Current liabilities    
Loans and notes payable 8,495 5,983
Accounts payable 11,991 10,311
Accrued liabilities 8,594 8,549
Accrued rebates, returns and promotions 19,124 17,580
Accrued compensation and employee related obligations 4,534 4,126
Accrued taxes on income 1,388 3,772
Total current liabilities 54,126 50,321
Long-term debt 39,438 30,651
Deferred taxes on income 6,791 2,448
Employee related obligations 6,957 7,255
Long-term taxes payable 486 390
Other liabilities 9,868 17,549
Total liabilities 117,666 108,614
Commitments and Contingencies
Shareholders’ equity    
Preferred stock — without par value (authorized and unissued 2,000,000 shares) 0 0
Common stock — par value $1.00 per share (Note 12) (authorized 4,320,000,000 shares; issued 3,119,843,000 shares) 3,120 3,120
Accumulated other comprehensive income (loss) (14,930) (11,741)
Retained earnings and Additional-paid-in-capital 168,978 155,791
Less: common stock held in treasury, at cost (Note 12) (711,904,000 shares and 712,921,000 shares) 75,624 75,680
Total shareholders’ equity 81,544 71,490
Total liabilities and shareholders’ equity $ 199,210 $ 180,104